Skip to main content
SpringerLink
Log in

Celecoxib CV risk increased at higher dosages

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Solomon SD, Wittes J, Hawk E, Cross Trial Safety.Trials: the Cross-Trials Safety Assessment pooled analysis. 57th Annual Scientific Session of the American College of Cardiology: Late Breakers: (plus oral presentation) abstr. 407-6, 29 Mar 2008

  2. American College of Cardiology.Cardiovascular Risk Differs by Celecoxib Dose. Media Release: 31 Mar 2008. Available from: URL: http://www.acc.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Celecoxib CV risk increased at higher dosages. React. Wkly. 1197, 3 (2008). https://doi.org/10.2165/00128415-200811970-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811970-00007

Keywords

Search

Navigation